{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-010212","form_type":"8-K","ticker":"ELVN","cik":"0001672619","company_name":"Enliven Therapeutics, Inc.","filed_at":"2022-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.743704+00:00","generated_at":"2026-06-26T22:49:42.803862+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Imara reports FY2021 net loss $51.4M; interim Phase 2b data expected April 2022","bullets":["Net loss $51.4M ($2.37 per share) vs $49.2M ($3.53 per share) in FY2020; cash $90.3M at Dec 31, 2021.","Phase 2b SCD and beta-thalassemia trials fully enrolled; interim data from both trials expected first week of April 2022.","FDA required change of Ardent SCD trial primary endpoint to annualized VOC rate; conduct unchanged.","Added HFpEF indication for tovinontrine; Phase 2 trial dosing expected Q2 2022; pipeline expanded with IMR-261.","FY2022 guidance: R&D $60-65M, G&A $13-15M; cash runway through Q1 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-010212","json":"https://secwatch.observer/filing/0001564590-22-010212.json","markdown":"https://secwatch.observer/filing/0001564590-22-010212.md","text":"https://secwatch.observer/filing/0001564590-22-010212.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1672619/000156459022010212/0001564590-22-010212-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1672619/000156459022010212/imra-8k_20220315.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:49:42.803862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}